BK vs SER · P/E 17, rev $20.08B vs rev $56.0K
The Bank of New York Mellon Corporation (BK) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the BK and SER stock pages for the full models.
Not investment advice.